Inpharma Weekly

, Volume 959, Issue 1, pp 16–16 | Cite as

Cancer patients prefer granisetron

Newsletter Article


Ondansetron Patient Preference Individual Response Ifosfamide Granisetron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1994

Personalised recommendations